JFG
BIOA

Jefferies Financial Group’s BioAge Labs BIOA Stock Holding History

Jefferies Financial Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,000
Closed -$207K – 1736
2025
Q2 		$207K Buy
+50,000
New +$201K ﹤0.01% 1115

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Jefferies Financial Group's BIOA Position: Q3 2025 in Review

Jefferies Financial Group sold out of BioAge Labs (BIOA) in Q3 2025, closing a stake of 50,000 shares — an estimated $207K sold.

Jefferies Financial Group first reported a position in BIOA in Q2 2025 and held it in 1 quarter. The position peaked at $207K in Q2 2025. 94 funds tracked by Wall St. Rank hold BIOA as of Q3 2025.

  • Jefferies Financial Group reported no remaining BioAge Labs position as of Q3 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 50,000 BioAge Labs shares in Q3 2025, an estimated $207K.
  • Jefferies Financial Group first reported a position in BioAge Labs in Q2 2025 and held it in 1 quarter.
  • Jefferies Financial Group's BioAge Labs position peaked at $207K in Q2 2025.
  • 94 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2025.

Based on Jefferies Financial Group's 13F filing for Q3 2025, filed 13 Nov 2025.